FDA Warning Letter — Janssen Pharmaceuticals, dba Actelion Pharmaceutical
The FDA took a Warning Letter action against Janssen Pharmaceuticals, dba Actelion Pharmaceutical on September 14, 2010 (South San Francisco, CA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Janssen Pharmaceuticals, dba Actelion Pharmaceutical
- Date
- September 14, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Center
- CDER
- Location
- South San Francisco, CA (United States)